2

FDA calls for subscription model to pay for anti-infectives

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2018
Language:
english
File:
PDF, 204 KB
english, 2018
3

Checkpoint inhibitors go viral

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2019
Language:
english
File:
PDF, 436 KB
english, 2019
4

Billion-dollar deals end eras of Ariad and Actelion

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2017
Language:
english
File:
PDF, 557 KB
english, 2017
5

Rollout of high-priced cell and gene therapies forces payer rethink

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2018
Language:
english
File:
PDF, 713 KB
english, 2018
6

Sovaldi makes blockbuster history, ignites drug pricing unrest

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2014
Language:
english
File:
PDF, 372 KB
english, 2014
7

Europe’s biotech renaissance

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2020
File:
PDF, 1.04 MB
2020
8

Novartis signs up for Google smart lens

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2014
Language:
english
File:
PDF, 149 KB
english, 2014
9

Beating the organ clock

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2018
Language:
english
File:
PDF, 270 KB
english, 2018
10

Texas displays 'Silicon Valley' credentials to lure Brazilian biotechs

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2018
Language:
english
File:
PDF, 2.64 MB
english, 2018
11

Google, Novartis back Medicxi's ambitions

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2017
Language:
english
File:
PDF, 1.12 MB
english, 2017
12

After Glybera's withdrawal, what's next for gene therapy?

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2017
Language:
english
File:
PDF, 220 KB
english, 2017
13

The price of priority review: $67.5 million

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2014
Language:
english
File:
PDF, 242 KB
english, 2014
14

Foundation receives $3.3-billion windfall for Kalydeco

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2015
Language:
english
File:
PDF, 495 KB
english, 2015
15

FDA halts then allows sales of Ariad's leukemia medication

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2014
Language:
english
File:
PDF, 2.62 MB
english, 2014
16

Heart drug pushes outcome-based pricing plans

Senior, Melanie
Journal:
Nature Reviews Drug Discovery
Year:
2015
Language:
english
File:
PDF, 414 KB
english, 2015
17

Biotechs recoil at hedge fund manager's patent attacks

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2015
Language:
english
File:
PDF, 537 KB
english, 2015
19

Big-cap buying bonanza trickles down to small biotech

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2014
Language:
english
File:
PDF, 683 KB
english, 2014
21

UK funding agencies weigh in on human germline editing

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2015
Language:
english
File:
PDF, 270 KB
english, 2015
23

Appetite for cheaper biologics spreads across the map

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2013
Language:
english
File:
PDF, 541 KB
english, 2013
24

Biosimilars battle rages on, Amgen fights both sides

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2013
Language:
english
File:
PDF, 168 KB
english, 2013
25

Amgen fined $762 million

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2013
Language:
english
File:
PDF, 108 KB
english, 2013
26

Family offices bolster early-stage financing

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2013
Language:
english
File:
PDF, 378 KB
english, 2013
27

J&J courts biotech in clusters

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2013
Language:
english
File:
PDF, 254 KB
english, 2013
28

Drugs with breakthrough status charm investors

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2013
Language:
english
File:
PDF, 953 KB
english, 2013
29

‘Scientific wellness’ searches for a business model

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2019
Language:
english
File:
PDF, 750 KB
english, 2019
31

The biopharmaceutical anomaly

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2020
File:
PDF, 988 KB
2020
32

Spreading biotech dollars around Washington

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2013
Language:
english
File:
PDF, 222 KB
english, 2013
33

First US biosimilar edges towards market

Senior, Melanie
Journal:
Nature Biotechnology
Year:
2015
Language:
english
File:
PDF, 270 KB
english, 2015